Long Noncoding RNAs as Emerging Regulators of COVID-19
COVID-19의 새로운 조절자로서의 긴 비코딩 RNA
Review
[키워드] (Tocilizumab)
acute respiratory syndrome
acute respiratory syndrome coronavirus
acute respiratory syndrome coronavirus-2
Antiviral
antiviral immune response
antiviral immune responses
antiviral role
biological processe
biological processes
cellular
changes in
Clinical treatment
coronavirus disease
Coronavirus disease 2019
Coronavirus-2
COVID-19
COVID-19 treatment
death
Dexamethasone
disease
drug
Evidence
expression
glucocorticoid
Glucocorticoids
help
Host
host transcriptome
immune dysfunction
Immune escape
immune responses
incidence rate
indicate
Infection
Inflammatory response
inhibiting
interferons
involved
lncRNA
lncRNAs
Long
long noncoding RNA
mechanisms
monoclonal antibodies
monoclonal antibody
Occurrence
pandemic
pathology
regulate
Regulation
regulator
Research
respiratory
resulting
RNA
SARS-CoV-2
SARS-COV-2 infection
Severe acute respiratory syndrome
severe acute respiratory syndrome Coronavirus
severe acute respiratory syndrome coronavirus-2
Spread
subsequent
therapeutic
thrombosis
Tocilizumab
Transcriptome
Treatment
type I interferon
type I interferons
up-regulate
Viral
viral gene
viral genes
viral infections
viral replication
virus infection
virus infections
[DOI] 10.3389/fimmu.2021.700184 PMC 바로가기 [Article Type] Review
[DOI] 10.3389/fimmu.2021.700184 PMC 바로가기 [Article Type] Review